Prognostic Value of Biomarkers in Polyneuropathy.
Status
Conditions
Details and patient eligibility
About
Biomarkers for prognosis of patients with polyneuropathy.
Full description
AIM: To investigate biomarkers' use as a prognostic tool in polyneuropathy patients.
STUDY DESIGN: Prospective cohort study of patients with polyneuropathy. METHODS: 200 patients with polyneuropathy will be examined with physical tests, medical examination, questionnaires, and blood biomarkers at baseline and at 1-year follow-up, and 2-year follow-up.
ANALYSIS: The investigators will calculate the odds of disease progression after 2 years depending on biomarkers levels at baseline using multiple logistic regression with sex and age adjustment. Diagnostic performance of the physical tests and biomarkers for prediction of disease progression will be assessed by Receiver Operating Characteristic Curve analysis with the area under the curve.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Minimum 18 years old.
- Diagnosed with polyneuropathy, confirmed by nerve conduction study.
- Can read and understand Danish.
Exclusion criteria
- Inability to perform physical tests due to comorbidity not associated to the patient's polyneuropathy.
Trial contacts and locations
Loading...
Central trial contact
Tina Dysgaard, Dr.med.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal